General
Preferred name
succinylcholine
Synonyms
Suxamethonium chloride ()
SUCCINYLCHOLINE CHLORIDE ()
choline chloride succinate ()
Succinyldicholine dichloride ()
Suxamethonium Chloride Dihydrate ()
SUXAMETHONIUM ()
Succinylcholine Chloride Dihydrate ()
Trimethyl[2-({4-oxo-4-[2-(trimethylammonio)ethoxy]butanoyl}oxy)ethyl]ammonium ()
Succinylcholine cation ()
Succinylcholine ()
Suxamethonium ion ()
Succinylcholine ion ()
Suxamethonium cation ()
Suxamethonium Chloride ()
Suxamethonii chloridum ()
Quelicin ()
Suxamethonium chloride dihydrate ()
Sucostrin ()
Suxamethonium chloride hydrate ()
NSC-49132 ()
Cloruro de suxametonio ()
Suxamethone ()
Chlorure de suxamethonium ()
Scoline ()
Quelicin Preservative Free ()
Anectine ()
Choline chloride succinate (2:1) ()
NSC-151059 ()
Succinylcholine bromide ()
SUXAMETHONIUM BROMIDE ()
Succinylcholine (chloride hydrate) ()
P&D ID
PD010173
CAS
6101-15-1
306-40-1
10168-63-5
71-27-2
Tags
available
drug
drug candidate
Approved by
FDA
First approval
1952
Drug indication
Stroke
Spasm
Drug Status
approved
investigational
Max Phase
4.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PRICE 29
DESCRIPTION Succinylcholine (sux) is a short-acting depolarizing neuromuscular blocker. It acts as an acetylcholine agonist at nicotinic acetylcholine receptors at neuromuscular junctions, resulting in persistent depolarization of the motor end plate. (GtoPdb)
DESCRIPTION Succinylcholine Chloride Dihydrate is a nicotinic AChR agonist and also acts as a depolarizing neuromuscular blocker. (BOC Sciences Bioactive Compounds)
DESCRIPTION Succinylcholine Chloride Dihydrate (Succinyldicholine dichloride) is a nicotinic AChR agonist and also acts as a depolarizing neuromuscular blocker. (TargetMol Bioactive Compound Library)
DESCRIPTION Nicotinic acetylcholine receptor antagonist. (LOPAC library)
Cell lines
1
Organisms
0
Compound Sets
28
Cayman Chemical Bioactives
CeMM library of unique drugs (CLOUD)
ChEMBL Approved Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Concise Guide to Pharmacology 2025/26
CZ-OPENSCREEN Bioactive Library
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
Enamine Bioactive Compounds
Guide to Pharmacology
Ki Database
LOPAC library
NCATS Inxight Approved Drugs
NPC Screening Collection
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
External IDs
121
Properties
(calculated by RDKit )
Molecular Weight
290.22
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
0
Rotatable Bonds
9
Ring Count
0
Aromatic Ring Count
0
cLogP
0.27
TPSA
52.6
Fraction CSP3
0.86
Chiral centers
0.0
Largest ring
0.0
QED
0.45
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Selectivity
Nicotinic
MOA
nicotinic acetylcholine receptor antagonist
AChR agonist
Target
Muscle-type nicotinic acetylcholine receptor
nAChR
CHRFAM7A, CHRM1, CHRM2, CHRM3, CHRNA1, CHRNA10
AChR
Indication
muscle relaxant
Pathway
Neuroscience
Therapeutic Class
Analgesics
Solubility
Soluble in DMSO (Slightly, Sonicated), Methanol (Slightly), Water (Slightly)
Source data